Drug Policy and the Public Good

Drug Policy and the Public Good

Paperback

By (author) Thomas F. Babor, By (author) Jonathan P. Caulkins, By (author) Griffith Edwards, By (author) Benedikt Fisher, By (author) David R. Foxcroft, By (author) Keith Humphreys, By (author) Isidore S. Obot, By (author) Jurgen T. Rehm, By (author) Peter Reuter, By (author) Robin Room

$55.89

Free delivery worldwide
Available
Dispatched in 2 business days
When will my order arrive?

  • Publisher: Oxford University Press
  • Format: Paperback | 352 pages
  • Dimensions: 156mm x 230mm x 24mm | 522g
  • Publication date: 1 March 2010
  • Publication City/Country: Oxford
  • ISBN 10: 0199557128
  • ISBN 13: 9780199557127
  • Illustrations note: 9 black and white line drawings
  • Sales rank: 452,979

Product description

Drug use represents a significant burden to public health through disease, disability and social problems, and policy makers are becoming increasingly interested in how to develop evidence-based drug policy. It is therefore crucial to strengthen the links between addiction science and drug policy.Drug Policy and the Public Good is collaboratively written by an international group of career scientists to provide an analytical basis on which to build relevant global drug policies, and to inform policy makers who have direct responsibility for public health and social welfare. Drug Policy and the Public Good presents, in a comprehensive, practical, and readily accessible form, the accumulated scientific knowledge on illicit drugs that has direct relevance to the development of drug policy on local, national, and international levels. The authors describe the conceptual basis for a rational drug policy and present new epidemiological data on the global dimensions of drug misuse. The core of the book is a critical review of the cumulative scientific evidence in five general areas of drug policy: primary prevention programs in schools and other settings; supply reduction approaches, including drug interdiction and legal enforcement; treatment interventions and harm reduction approaches; criminal sanctions and decriminalization; and control of the legal market through prescription drug regimes. The final chapters discuss the current state of drug policy in different parts of the world, and describe the need for a new approach to drug policy that is evidence-based, realistic, and co-ordinated. The authors describe the conceptual basis for a rational drug policy and present new epidemiological data on the global dimensions of drug misuse. The core of the book is a critical review of the cumulative scientific evidence in five general areas of drug policy: primary prevention programs in schools and other settings; supply reduction approaches, including drug interdiction and legal enforcement; treatment interventions and harm reduction approaches; criminal sanctions and decriminalization; and control of the legal market through prescription drug regimes. The final chapters discuss the current state of drug policy in different parts of the world, and describe the need for a new approach to drug policy that is evidence-based, realistic, and co-ordinated. By locating drug policy primarily within the realm of public health, this book draws attention to the growing tendency of governments, both national and local, to consider illegal psychoactive substances as a major determinant of ill health, and to organize societal responses accordingly. It will appeal to those involved in both addiction science and drug policy, as well as those in the wider fields of public health, health policy, epidemiology, primary prevention, and treatment services. A companion volume published by Oxford University Press, Alcohol: no ordinary commodity - research and public policy, is also available.

Other people who viewed this bought:

Showing items 1 to 10 of 10

Other books in this category

Showing items 1 to 11 of 11
Categories:

Author information

Professor John Strang is a leading Addictions clinician and academic, with 30 years' experience in various aspects of the diverse addictions treatment field. He is Director of the National Addiction Centre (NAC) covering both the academic work of the Addiction Research Unit at the Institute of Psychiatry and also the clinical services for people seeking help with drug or alcohol problems across South London and more widely. In addiction to his academic interest (with more than 300 addictions publications), he has been a consultant psychiatrist in the addictions for 26 years and has extensive experience as a lead clinician in charge of a wide range of treatments in community and residential settings. He has good working links with a range of non-statutory residential treatment providers of care and rehabilitation, including Clouds house (12-Step) and Phoenix Futures (Therapeutic community).

Review quote

It is a must read - and a very easy and enjoyable one - for any one concerned with drug policy. All readers will find themselves armed with essential relevant and contemporary context and evidence both nationally and internationally. BMA Medical Book Competition

Table of contents

PART 1 - INTRODUCTION ; 1. Framing the issues ; 2. Matters of substance ; PART 2 - DRUG EPIDEMIOLOGY AND DRUG MARKETS ; 3. The international dimensions of drug use ; 4. Harms associated with illicit drug use ; 5. Illegal markets: the economics of drug distribution and social harm ; 6. The legal market: prescription and diversion of psychopharmaceuticals ; PART 3 - THE EVIDENCE BASE FOR DRUG POLICY: RESEARCH ON STRATEGIES AND INTERVENTIONS ; 7. Strategies and interventions to reduce drug use and related harm: section overview ; 8. Preventing illicit drug use by young people ; 9. Health and social services for drug users ; 10. Supply control ; 11. Criminalization and decriminalization of drug use or possession ; 12. Prescription regimes and other measures to control misuse of psychopharmaceuticals ; PART 4 - THE POLICY ARENA ; 13. Drug Policy and Control at the International Level ; 14. The Variety of National Drug Policies ; 15. Health and social services for drug users: systems issues ; PART 5 - SYNTHESIS AND CONCLUSIONS ; 16. Summary and conclusions ; Appendix A